OABI Q1 2022 Earnings — OmniAb, Inc. Revenue & Financial Results | Market Cap Arena

OABIOmniAb, Inc.

$231M

Q1 2022 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$10M+45.9% YoY

Gross Profit

$6M58.4% margin

Operating Income

-$9M-90.1% margin

Net Income

-$6M-65.3% margin

EPS (Diluted)

$-0.05

QoQ Revenue Growth

-37.0%

Cash Flow

Operating Cash Flow

$12M

Free Cash Flow

$8M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$237M

Total Liabilities

$14M

Stockholders' Equity

$223M

Cash & Equivalents

$434,629

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$10M	$7M	+45.9%
Gross Profit	$6M	$7M	-14.8%
Operating Income	-$9M	-$10M	+16.4%
Net Income	-$6M	-$8M	+21.9%